Published in
Public Library of Science, PLoS Pathogens, 6(16), p. e1008522, 2020
DOI: 10.1371/journal.ppat.1008522
Links
Tools
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial
Journal article published in 2020 by
Yves Lévy 
,
Christine Lacabaratz ,
Kim Ellefsen-Lavoie,
Wolfgang Stöhr,
Jean-Daniel Lelièvre,
Pierre-Alexandre Bart,
Odile Launay,
Jonathan Weber,
Bernd Salzberger,
Aurélie Wiedemann ,
Mathieu Surenaud ,
David M. Koelle,
Hans Wolf,
Ralf Wagner,
Véronique Rieux
and other authors.
,
Christine Lacabaratz ,
Kim Ellefsen-Lavoie,
Wolfgang Stöhr,
Jean-Daniel Lelièvre,
Pierre-Alexandre Bart,
Odile Launay,
Jonathan Weber,
Bernd Salzberger,
Aurélie Wiedemann ,
Mathieu Surenaud ,
David M. Koelle,
Hans Wolf,
Ralf Wagner,
Véronique Rieux
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 